Motivational letter should be in English, with a maximum of 200 words. Describe briefly why you would like to attend the summer school and what you wish to learn.
Abstract should be in English, with a maximum of 250 words.
We welcome contributions from across the full spectrum of the scientific and clinical community. Whether you are new to the field, generating primary data, developing enabling technologies, or identifying clinical needs, your perspective is vital to advancing the field of immunopeptidomics. Please select the Submission Track that best aligns with your current work and objectives:
Track 1: Future Research Directions (Early-Stage/New to Field)
Students, researchers, or professionals transitioning into immunopeptidomics who have not yet generated primary data in this specific field.
Focus: Identify a biological question or a specific disease area you are currently working on (or plan to work on). Describe how you intend to apply immunopeptidomics to this problem and what impact you anticipate this will have on your research.
Track 2: Scientific Research
Researchers currently conducting studies in immunopeptidomics or related fields.
Focus: Outline your hypothesis, methodology, key findings, and the significance of your results to the broader field.
Track 3: Technology & Therapeutic Innovation
Developers, engineers, and industry professionals working on novel therapeutic modalities (e.g., cell therapies, vaccines, or multispecifics) seeking to integrate antigen discovery into their design.
Focus: Describe your technology platform or therapeutic approach and specify how the identification of novel antigens will help you design or refine next-generation modalities.
Track 4: Clinical Application & Translation
Clinicians, medical specialists, and translational scientists focused on patient outcomes and unmet medical needs.
Focus: Identify a specific clinical gap or "pain point" in patient care and explain how deeper insights into the immunopeptidome could provide a solution or improve diagnostic/therapeutic pathways.
*Please do not include any charts, bibliographies or footnotes.